Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Salicylic ointment is a topical keratolytic preparation containing salicylic acid as its active pharmaceutical ingredient. It is primarily indicated for the treatment of hyperkeratotic skin conditions, including warts, calluses, corns, and chronic plaque psoriasis. The mechanism of action involves the dissolution of the intercellular cement in the stratum corneum, which promotes the shedding of epidermal cells and softens the skin. Additionally, salicylic acid exhibits mild anti-inflammatory and antiseptic properties. Viola Pharm, a pharmaceutical manufacturer based in Ukraine, produces this formulation as a generic over-the-counter (OTC) product.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on salicylic ointment.